The course of neurocognitive functioning in high-grade glioma patients

Neuro-Oncology

Volumn 9, Issue 1, 2007, Pages 53-62

  Bosma, Ingeborg ^a   Vos, Maaike J ^a   Heimans, Jan J ^a   Taphoorn, Martin J B ^b,c   Aaronson, Neil K ^d   Postma, Tjeerd J ^a   Van Der Ploeg, Henk M ^a   Muller, Martin ^d   Vandertop, W Peter ^a   Slotman, Ben J ^a   Klein, Martin ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

High grade glioma; Neurocognitive functioning; Neuropsychological assessment; Prospective study; Tumor recurrence

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; DEXAMETHASONE; FLUOROURACIL; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; ATTENTION; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; COGNITION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLIOMA; HUMAN; INFORMATION PROCESSING; MALE; PSYCHOMOTOR ACTIVITY; VERBAL MEMORY; WORKING MEMORY; BRAIN DISEASE; CANCER STAGING; CASE CONTROL STUDY; COGNITIVE DEFECT; COMPARATIVE STUDY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; TUMOR RECURRENCE;

ADULT; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS; BRAIN DISEASES; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE;

EID: 34047226861     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/15228517-2006-012     Document Type: Article

References (36)

1. Anderson, S.I., Taylor, R., and Whittle, I.R. (1999) Mood disorders In patients after treatment for primary intracranial tumours. Br. J. Neurosurg. 13, 480-485.
2. Archibald, Y.M., Lunn, D., Ruttan, L.A., Macdonald, D.R., Del Maestro, R.F., Barr, H.W., Pexman, J.H., Fisher, B.J., Gaspar, L.E., and Cairncross, J.G. (1994) Cognitive functioning in long-term survivors of high-grade glioma. J. Neurosurg. 80, 247-253.
3. Benton, A.L. (1968) Differential behavioral effects in frontal lobe disease. Neuropsychologia 6, 53-60.
4. Benton, A.L., and Van Allen, M.W. (1968) Impairment in facial recognition in patients with cerebral disease. Trans. Am. Neurol. Assoc. 93, 38-42.
5. Crossen, J.R., Garwood, D., Glatstein, E., and Neuwelt, E.A.(1994)Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy. J. Clin. Oncol. 12, 627-642.
6. Curran, WJ., Jr., Scott, C.B., Horton, J., Nelson, J.S., Weinstein, A.S., Fischbach, A.J., Chang, C.H., Rotman, M., Asbell, S.O., Krisch, R.E., and Nelson, D.F. (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J. Natl. Cancer, Inst 85, 704-710.
7. Donahue, B., Scott, C.B., Nelson, J.S., Rotman, M., Murray, K.J., Nelson, D.F., Banker, F.L., Earle, J.D., Fischbach, J.A., Asbell, S.O., Caspar, L.E., Markoe, A.M., and Curran, W. (1997) Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: A report of Radiation Therapy Oncology Group 83-02. Int. J. Radiat. Oncol. Biol. Phys. 38, 911-914.
8. Gregor, A., Cull, A., Traynor, E., Stewart, M., Lander, F., and Love, S. (1996) Neuropsychometric evaluation of long-term survivors of adult brain tumours: Relationship with tumour and treatment parameters. Radiother. Oncol. 41, 55-59.
9. Hahn, C.A., Dunn, R.H., Logue, P.E., King, J.H., Edwards, C.L., and Halperin, E.C. (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 55, 992-999.
10. Hess, K.R., Broglio, K.R., and Bondy, M.L. (2004) Adult glioma incidence trends in the United States, 1977-2000. Cancer 101, 2293-2299.
11. Houx, P.J., and Jolles, J. (1994) Vulnerability factors for age-related cognitive decline. In: Isaacson, R.L., and Jensen, K.F. (Eds.), The Vulnerable Brain and Environmental Risks, Vol. 3. New York: Plenum Press, pp. 25-41.
12. Jolles, J., Houx, P.J., van Boxtel, M.P.J., and Ponds, R.W.H.M. (Eds.) (1995) Maastricht Aging Study: Determinants of Cognitive Aging, Maastricht, The Netherlands: Neuropsych Publishers.
13. Kaiser, H.F. (1958) The varimax criterion for analytic rotation in factor analysis. Psychometrika 23, 187-200.
14. Kaleita, T.A., Wellisch, O.K., Cloughesy, T.F., Ford, J.M., Freeman, D., Belin, T.R., and Goldman, J. (2004) Prediction of neurocognitive outcome in adult brain tumor patients. J. Neurooncol. 67, 245-253.
15. Kayl, A.E., and Meyers, C.A. (2003) Does brain tumor histology influence cognitive function? Neuro-Oncology 5, 255-260.
16. Klein, M., Taphoorn, M.J., Heimans, J.J., van der Ploeg, H.M., Vandertop, W.P., Smit, E.F., Leenstra, S., Tulleken, C.A., Boogerd, W., Belderbos, J.S., Cleijne, W., and Aaronson, N.K. (2001) Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients (erratum in J. Clin. Oncol. [2003] 21, 2628). J. Clin. Oncol. 19, 4037-4047
17. Klein, M., Heimans, J.J., Aaronson, N.K., van der Ploeg, H.M., Grit, J., Muller, M., Postma, T.J., Mooij, J.J., Boerman, R.H., Beute, G.N., Ossenkoppele, G.J., van Imhoff, G.W., Dekker, A.W., Jolies, J., Slotman, B.J., Struikmans, H., and Taphoorn, M.J. (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: A comparative study. Lancet 360, 1361-1368.
18. Klein, M., Postma, T.J., Taphoorn, M.J., Aaronson, N.K., Vandertop, W.P., Muller, M., van der Ploeg, H.M., and Heimans, JJ. (2003a) The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology 61, 1796-1798.
19. Klein, M., Engelberts, N.H., van der Ploeg, H.M., Kasteleijn-Nolst Trenite, D.G., Aaronson, N.K., Taphoorn, M.J., Baaijen, H., Vandertop, W.P., Muller, M., Postma, T.J., and Heimans, J.J. (2003b) Epilepsy in low-grade gliomas: The impact of cognitive function and quality of life. Ann. Neurol. 54, 514-520.
20. Lezak, M.D. (1995) Neuropsychological Assessment. New York: Oxford University Press.
21. Lindeboom, J., and Jonker, C. (1989) Amsterdam Dementia Screening Test ADS6. Lisse, The Netherlands: Swets and Zeitlinger.
22. Meyers, C.A., and Hess, K.R. (2003) Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression. Neuro-Oncology 5, 89-95.
23. Meyers, C.A., Hess, K.R., Yung, W.K.A., and Levin, V.A. (2000) Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J. Clin. Oncol. 18, 646-650.
24. Olson, I.D., Riedel, E., and DeAngelis, L.M. (2000) Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54, 1442-1448.
25. Salander, P., Karlsson, T., Bergenheim, T., and Henriksson, R. (1995) Long-term memory deficits in patients with malignant glioma. J. Neurooncol. 25, 227-238.
26. Schenkenberg, T., Bradford, D.C., and Ajax, ET. (1980) Line bisection and unilateral visual neglect in patients with neurologic impairment. Neurology 30, 509-517.
27. Schmand, B., Bakker, D., Saan, R., and Louman, J. (1991) [The Dutch Reading Test for Adults: A measure of premorbid intelligence level.] Tijdschr. Gerontol. Geriatr. 22, 15-19.
28. Scott, C.B., Scarantino, C., Urtasun, R., Movsas, B., Jones, C.U., Simpson, J.R., Fischbach, A.J., and Curran, W.J., Jr. (1998) Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: A report using RTOG-90-06. Int. J. Radial Oncol. Biol. Phys. 40, 51-55.
29. Sheline, G.E., Wara, W.M., and Smith, V. (1980) Therapeutic irradiation and brain injury. Int. J. Radiat. Oncol. Biol. Phys. 6, 1215-1228.
30. Sternberg, S. (1975) Memory scanning: New findings and current controversies. Q. J. Exp. Psychol. 27, 1-32.
31. Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R.C., Ludwin, S.K., Gorlia, T, Allgeier, A., Lacombe, D., Cairncross, J.G., Eisenhauer, E., and Mirimanoff, R.O. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996.
32. Swennen, M.H., Bromberg, J.E., Witkamp, T.D., Terhaard, C.H., Postma, T.J., and Taphoorn, M.J. (2004) Delayed radiation toxicity after focal or whole brain radiotherapy for low-grade glioma. J. Neurooncol. 66, 333-339.
33. Taphoorn, M.J. (2003) Neurocognitive sequelae in the treatment of low-grade gliomas. Semin. Oncol. 30, 45-48.
34. Taphoorn, MJ., and Klein, M. (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 3,159-168.
35. Taylor, B.V., Buckner, J.C., Cascino, T.L., O'Fallon, J.R., Schaefer, P.L., Dinapoli, R.P., and Schomberg, P. (1998) Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J. Clin. Oncol. 16, 2195-2201.
36. Woodard, J.L., Benedict, R.H., Roberts, V.J., Goldstein, F.C., Kinner, K.M., Capruso, D.X., and Clark, A.N. (1996) Short-form alternatives to the judgment of Line Orientation Test. J. Clin. Exp. Neuropsychol. 18, 898-904.